HIGHLY EMETOGENIC CHEMOTHERAPY

Clinical trials for HIGHLY EMETOGENIC CHEMOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new HIGHLY EMETOGENIC CHEMOTHERAPY trials appear

Sign up with your email to follow new studies for HIGHLY EMETOGENIC CHEMOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New combo may reduce steroid use for chemo side effects

Symptom relief Completed

This study tested whether using less dexamethasone (a steroid) along with two other drugs (NEPA and olanzapine) can still prevent nausea and vomiting caused by strong chemotherapy. 644 adults receiving high-risk chemo took part. The goal was to see if the reduced-steroid approach…

Matched conditions: HIGHLY EMETOGENIC CHEMOTHERAPY

Phase: PHASE3 • Sponsor: Fudan University • Aim: Symptom relief

Last updated May 01, 2026 15:57 UTC

HIGHLY EMETOGENIC CHEMOTHERAPY

Get alerted when new HIGHLY EMETOGENIC CHEMOTHERAPY trials appear

New combo may reduce steroid use for chemo side effects